Table 3.
Extensively drug-resistant strain prevalence in COVID-19 patients at UHK
| XDR prevalence according to selected factors [%] |
XDR | p-value | |
|---|---|---|---|
| No | Yes | ||
| Age median (Q1;Q3) [years] | 69 (63;75) | 66 (63;73) | 0.106 |
| HAIs N [%] | |||
| PNA | 78 (66.1%) | 40 (33.9%) | 0.008 |
| UTI | 107 (79.9%) | 27 (20.1%) | |
| BSI | 48 (87.3%) | 7 (12.7%) | |
| Others | 14 (82.4%) | 3 (17.6%) | |
| ICU N [%] | |||
| Yes | 196 (75.1%) | 65 (24.9%) | 0.415 |
| No | 51 (81.0%) | 12 (19.0%) | |
| Sex N [%] | |||
| Female | 103 (83.1%) | 21 (16.9%) | 0.029 |
| Male | 142 (71.7%) | 56 (28.3%) | |
| Etiological factors N [%] | |||
| Staphylococcus aureus | 36 (100.0%) | 0 (0.0%) | < 0.001 |
| Enterococcus spp. | 60 (100.0%) | 0 (0.0%) | |
| Escherichia coli | 45 (100.0%) | 0 (0.0%) | |
| Klebsiella spp. | 32 (75.0%) | 11 (25.0%) | |
| Acinetobacter spp | 12 (19.0%) | 51 (81.0%) | |
| Others | 55 (80.9%) | 13 (19.1%) | |
Legend: BSI: bloodstream infection; HAI: healthcare-associated infections; ICU: intensive care unit; PNA: pneumonia; UTI: urinary tract infection; Q1: first quartile; Q3: third quartile; XDR: extensively drug-resistant; UHK: University Hospital in Kraków